Clinical Trials Directory

Trials / Completed

CompletedNCT00610064

Brain Effects of Sacral Neuromodulation

Brain Effects of Sacral Neuromodulation in Patients With Refractory Lower Urinary Tract Dysfunction

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
30 (estimated)
Sponsor
Insel Gruppe AG, University Hospital Bern · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Sacral neuromodulation (SNM) has become an accepted treatment for patients with refractory lower urinary tract dysfunction such as urgency frequency syndrome, urgency incontinence, non-obstructive chronic urinary retention and chronic pelvic pain syndrome. Modulation of central afferent activity is considered critical to this therapeutic effect but the neural mechanisms are poorly understood. We hypothesize that SNM has a significant effect on brain activity detectable by positron emission tomography (PET).

Conditions

Interventions

TypeNameDescription
RADIATIONBaseline neuroimagingBaseline neuroimaging using PET and MRI of the brain in patients before sacral neuromodulation
RADIATIONNeuroimaging during sacral neuromodulationNeuroimaging during sacral neuromodulation using PET

Timeline

Start date
2005-10-01
Primary completion
2009-06-01
Completion
2009-06-01
First posted
2008-02-07
Last updated
2010-02-05

Locations

1 site across 1 country: Switzerland

Source: ClinicalTrials.gov record NCT00610064. Inclusion in this directory is not an endorsement.

Brain Effects of Sacral Neuromodulation (NCT00610064) · Clinical Trials Directory